Pharmacologic development of male hormonal contraceptive agents

Clin Pharmacol Ther. 2011 Jan;89(1):133-6. doi: 10.1038/clpt.2010.103. Epub 2010 Sep 8.

Abstract

The world population continues to increase dramatically despite the existence of contraceptive technology. The use of male hormonal contraception may help in preventing un intended pregnancies and managing future population growth. Male hormonal contraception relies on the administration of exogenous hormones to suppress spermatogenesis. Clinical trials have tested several regimens using testosterone, alone or in combination with a progestin. These regimens were shown to be >90% effective in preventing conception and were not associated with serious adverse events.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Animals
  • Contraceptive Agents, Male / adverse effects
  • Contraceptive Agents, Male / pharmacology*
  • Contraceptive Agents, Male / therapeutic use*
  • Drug Design*
  • Drugs, Investigational / adverse effects
  • Drugs, Investigational / pharmacology
  • Drugs, Investigational / therapeutic use
  • Humans
  • Male
  • Spermatogenesis-Blocking Agents / adverse effects
  • Spermatogenesis-Blocking Agents / pharmacology
  • Spermatogenesis-Blocking Agents / therapeutic use

Substances

  • Contraceptive Agents, Male
  • Drugs, Investigational
  • Spermatogenesis-Blocking Agents